Study of Dupilumab for the Treatment of Patients With Prurigo Nodularis, Inadequately Controlled on Topical Prescription Therapies or When Those Therapies Are Not Advisable (LIBERTY-PN PRIME)
Clinical trial NCT04183335 · COMPLETED
Trial details
- NCT number
- NCT04183335
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-12
- Primary completion
- 2021-11-12
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.